Very Low Dose Bevacizumab for the Treatment of Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia

by Andrew B. Thompson B.S., Douglas A. Ross M.D. F.A.C.S., Paul Berard M.D., Jaszmin Figueroa-Bodine M.D., Nancy Livada P.A.-C., Sara L. Richer M.D. F.A.C.S.
Published 2014-06-01